Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 30;44(4):1513-1527.
doi: 10.3390/cimb44040103.

Ulcerative Colitis Seems to Imply Oral Microbiome Dysbiosis

Affiliations

Ulcerative Colitis Seems to Imply Oral Microbiome Dysbiosis

Natalia Molinero et al. Curr Issues Mol Biol. .

Abstract

Ulcerative colitis (UC) is a recurrent pathology of complex etiology that has been occasionally associated with oral lesions, but the overall composition of the oral microbiome in UC patients and its role in the pathogenesis of the disease are still poorly understood. In this study, the oral microbiome of UC patients and healthy individuals was compared to ascertain the possible changes in the oral microbial communities associated with UC. For this, the salivary microbiota of 10 patients diagnosed with an active phase of UC and 11 healthy controls was analyzed by 16S rRNA gene sequencing (trial ref. ISRCTN39987). Metataxonomic analysis revealed a decrease in the alpha diversity and an imbalance in the relative proportions of some key members of the oral core microbiome in UC patients. Additionally, Staphylococcus members and four differential species or phylotypes were only present in UC patients, not being detected in healthy subjects. This study provides a global snapshot of the existence of oral dysbiosis associated with UC, and the possible presence of potential oral biomarkers.

Keywords: alpha diversity; differential abundance; dysbiosis; oral biomarkers; oral microbiome; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Boxplots representing the different alpha diversity indices (observed, Shannon, and Simpson) detected in the saliva samples of the UC patients and healthy subjects. Alpha indices that showed statistically differences (* p-value < 0.05) following the ANOVA test are marked with an asterisk.
Figure 2
Figure 2
Beta diversity analysis following the NMDS Bray–Curtis method for the UC patients and healthy subjects.
Figure 3
Figure 3
Linear discriminant analysis (LDA) scores (log10) for the significant taxonomic biomarkers obtained from the LEfSe analysis between the groups of healthy subjects and UC patients. Color code: green—taxa in higher proportions in the healthy group; red—taxa in higher proportions in UC participants.

References

    1. Miyoshi J., Chang E.B. The gut microbiota and inflammatory bowel diseases. Transl. Res. 2017;179:38–48. doi: 10.1016/j.trsl.2016.06.002. - DOI - PMC - PubMed
    1. Docktor M.J., Paster B.J., Abramowicz S., Ingram J., Wang Y.E., Correll M., Jiang H., Cotton S.L., Kokaras A.S., Bousvaros A. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 2012;18:935–942. doi: 10.1002/ibd.21874. - DOI - PMC - PubMed
    1. Lucas López R., Grande Burgos M.J., Gálvez A., Pérez Pulido R. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: A state of the science review. APMIS. 2017;125:3–10. doi: 10.1111/apm.12609. - DOI - PubMed
    1. Guo X.Y., Liu X.J., Hao J.Y. Gut microbiota in ulcerative colitis: Insights on pathogenesis and treatment. J. Dig. Dis. 2020;21:147–159. doi: 10.1111/1751-2980.12849. - DOI - PubMed
    1. Ribaldone D.G., Brigo S., Mangia M., Saracco G.M., Astegiano M., Pellicano R. Oral manifestations of inflammatory bowel disease and the role of non-invasive surrogate markers of disease activity. Medicines. 2020;7:33. doi: 10.3390/medicines7060033. - DOI - PMC - PubMed

LinkOut - more resources